Whilst they can hold this card close to their chest, my understanding is it's not their intent. The new appointments own realisation is that there is clearly a potential "blockbuster" status here so he'll engage with third parties on this basis. My personal expectations is that he won't have much difficulty fielding a win-win deal(s). I note PNV (David Willams) went down this path given it was a unique and unproven burn product that needed market traction in hospitals before it would attract the type of bid he's after. The market we'd be selling Zilosul into is materially different.
Whilst they can hold this card close to their chest, my...
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $66.54M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.0¢ | $203.4K | 1.019M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 387930 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 65468 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |